Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide, the active ingredient in Mounjaro, has a half life of approximately five days in the body. That single fact explains almost everything about why the medicine is taken once a week, what happens if you miss a dose, and how long it stays active after you stop. These are prescription-only medicines; a GPhC-registered prescriber assesses whether they are clinically appropriate for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A medicine's half life is the time it takes for its concentration in the blood to drop by 50 per cent. For tirzepatide, that figure is approximately five days. It sounds abstract until you consider the practical consequence: a single weekly injection keeps blood levels high enough throughout the full seven days to maintain appetite suppression and blood-sugar regulation without requiring daily dosing.
Compare that to short-acting medicines that need to be taken two or three times daily to stay effective, and the logic becomes clear. Tirzepatide was engineered as a long-acting molecule partly because its GIP and GLP-1 receptor activity depends on sustained exposure, not peaks and troughs. The once-weekly KwikPen is the delivery format that matches the biology, not an arbitrary convenience. You can read more about the full pharmacological profile on our tirzepatide overview page.
Reaching a steady state takes around four to five half lives. That means it takes roughly four weeks of weekly injections for Mounjaro to accumulate to a plateau in the bloodstream. This is one reason titration is gradual: the body is adapting to an increasing level of a long-acting molecule, not a brief daily spike.
Because tirzepatide has such a long half life, missing a single injection by a day or two has less pharmacological impact than missing a daily medicine would. Plasma levels do not crash overnight. That said, the decision about what to do when a dose is late or missed belongs entirely with your prescriber and the Patient Information Leaflet — this page is not the place for instructions on that.
What is useful to understand is the underlying reason clinical guidance typically allows some flexibility around injection timing. The five-day half life provides a buffer. It also explains why "catching up" by injecting twice in quick succession is not recommended: you would be layering doses into a system that still holds significant tirzepatide from the previous week.
Routine matters here too. Many people find attaching their injection day to something consistent (a Monday evening, a Sunday after lunch, or the same slot they check the week's calendar) reduces the chance of drift. Keeping the pen in the fridge door alongside something you already reach for daily is one small way to make the habit stick.
This is the question that drives most searches on tirzepatide's half life, and the answer has real implications for planning. Using the five-day half life as the baseline, plasma concentration falls to roughly 3 per cent of peak level after five half lives. Five half lives of five days each gives approximately 25 days. In practice, most clinical guidance refers to a washout of around four to five weeks before conception attempts or certain surgical procedures.
That clinical significance is worth pausing on. The MHRA advises that women planning to conceive should stop tirzepatide and allow a suitable washout period, and NHS England's guidance on weight-management injections notes that women using oral contraceptives should use an additional non-oral method for the first four weeks of treatment and after each dose increase, because tirzepatide's effect on gastric emptying may affect pill absorption. If your reason for checking how long Mounjaro stays in your system is related to pregnancy planning, surgery, or a specific medication interaction, the right conversation is with your prescriber, not a search engine.
For context on what happens to weight and appetite when treatment ends, our page on life after Mounjaro covers the evidence in detail, and there is related reading on long-term treatment duration for those weighing how long to continue.
Most people who search for tirzepatide's half life are trying to answer one of four real questions: why is it weekly, what happens if I miss one, how long before it clears my system, and is it building up in dangerous amounts? The five-day figure addresses all of them.
Accumulation is expected and designed in. Steady-state tirzepatide levels are higher than a single-dose level, but the titration schedule, starting at 2.5mg before increasing under clinical supervision, is designed to let the body adapt gradually. The clinical trials that demonstrated Mounjaro's effectiveness, including SURMOUNT-1 published in the New England Journal of Medicine, were conducted across this titration pathway, and the NHS medicines page for tirzepatide provides a patient-level summary of how the medicine works and what to monitor.
For those considering treatment costs alongside clinical decisions, our Mounjaro pricing page explains what a private prescription includes. A visual summary of concentration over time is available on our Mounjaro half life chart, and if you want to model timing for your own schedule, the tirzepatide half life calculator is a practical tool. For a broader view of the medicine, the Mounjaro treatment page covers eligibility, how treatment works at nume, and what to expect.
If any of these questions have a specific clinical dimension for your situation, the straightforward next step is a conversation with our team. A real prescriber reviews every consultation at nume — no algorithm involved.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.